|Daily Range||$40.51 - $41.30|
|52-Week Range||$23.61 - $53.93|
|Dividend (Yield)||$0.00 (0.0%)|
|Average Daily Volume||205,484|
|Current FY EPS||-$1.03|
CONTROLADORA VUELA SPON ADR REPR 10 CPOS (XLRN) Description
CONTROLADORA VUELA SPON ADR REPR 10 CPOS Website: http://www.acceleronpharma.com/
But it wasn't all the healthy kind of expansion.
Celgene Corporation has issued long-term guidance that suggests significant sales and profit growth through 2020.
Insys Therapeutics, Achillion Pharmaceuticals, Portola Pharmaceuticals, Ophthotech, and Acceleron Pharma have intriguing pipelines that may make them stocks to own this year.
Celgene Corp, Alkermes, GW Pharmaceuticals, Gilead Sciences, and Hospira should all be on investors radar in 2015.
Which drugs are poised to carry their makers into a healthy 2015? Industry Focus has three top picks.